$209.87
4.302.09%
가까이에: Sep 1, 5:00 PM EST
$210.74
0.870.41%
시간외: 7:47 PM EST
Benzinga
Benzinga
Benzinga
수요일, 9월 02
Revolution Medicines Inc
RVMDNASDAQ
Revolution Medicines Earnings & Forecasts
Revolution Medicines (RVMD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Revolution Medicines Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.01 | $-1.84 | $-1.56 | $-1.40 |
| Actual | $-3.06 | $-2.29 | $-1.86 | $-1.61 |
| Surprise | -52.2% | -24.5% | -19.2% | -15.0% |
| Revenue | ||||
| Estimate | $39.7M | $6.1M | $11.6M | $6.0M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | -100.0% | -100.0% | -100.0% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-2.43 | $-2.11 | $-1.70 | $-1.65 |
| Revenue | ||||
| Consensus | $14.4M | $139.5M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved